Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways-Reference-Cited by-同舟云学术

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

Published:2019-05-20 Issue:7 Volume:20 Page:915-927
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Der Evan, ,Suryawanshi Hemant,Morozov Pavel,Kustagi Manjunath,Goilav Beatrice,Ranabothu Saritha,Izmirly Peter,Clancy Robert,Belmont H. Michael,Koenigsberg Mordecai,Mokrzycki Michele,Rominieki Helen,Graham Jay A.^ORCID,Rocca Juan P.,Bornkamp Nicole,Jordan Nicole,Schulte Emma,Wu Ming,Pullman James^ORCID,Slowikowski Kamil^ORCID,Raychaudhuri Soumya^ORCID,Guthridge Joel^ORCID,James Judith,Buyon Jill^ORCID,Tuschl Thomas^ORCID,Putterman Chaim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-019-0386-1.pdf

Reference48 articles.

1. Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110–2121 (2011).

2. Mohan, C. & Putterman, C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat. Rev. Nephrol. 11, 329–341 (2015).

3. Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15, 241–250 (2004).

4. Yu, F. et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 international society of nephrology and renal pathology society system. Kidney Int. 77, 820–829 (2010).

5. Hsieh, C. et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 63, 865–874 (2011).

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus nephritis;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Overview of lupus pathogenesis;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Expanding the opportunities to effectively treat patients;Dubois' Lupus Erythematosus and Related Syndromes;2025

4. Pathogenesis of cutaneous lupus;Dubois' Lupus Erythematosus and Related Syndromes;2025

5. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus;International Immunopharmacology;2024-10